Q3 2012 reported sales increased 2% to $639 million. Sales grew organically by 2% with Research and Sigma-Aldrich Fine Chemicals (“SAFC”) organic sales growth of 1% and 5%, respectively. Acquisitions contributed 6% to sales growth. Changes in foreign currency exchange rates reduced otherwise reportable sales by 6%. Q3 2012 reported diluted EPS was $0.92 compared to $0.95 in Q3 2011. Excluding restructuring costs, Q3 2012 adjusted diluted EPS was $0.94 compared to $0.96 in Q3 2011. Changes in foreign currency exchange rates versus the same period last year reduced adjusted Q3 2012 EPS by $0.11. Excluding this impact, adjusted EPS would have grown by 9% from the same period last year. Q3 2012 had strong free cash flow generation of $122 million. YTD 2012 net cash provided by operating activities and free cash flow were $379 million and $290 million, respectively.
